As per MRFR analysis, the India Genomics Market Size was estimated at 1.51 (USD Billion) in 2023.The India Genomics Market Industry is expected to grow from 1.63(USD Billion) in 2024 to 3.25 (USD Billion) by 2035. The India Genomics Market CAGR (growth rate) is expected to be around 6.503% during the forecast period (2025 - 2035).
The India genomics market is undergoing substantial growth, which is being driven by key market drivers such as the increasing prevalence of genetic disorders and the growing demand for personalized medication. India is in dire need of genomic solutions due to the significant proportion of its population that is afflicted by genetically related health issues.
Government initiatives that are designed to encourage healthcare advancements, such as the National Health Mission and the Indian government's promotion of biotechnology, are further accelerating the progress in this field. The trend toward direct-to-consumer genetic testing and ancestry analysis has gained popularity in recent times, primarily as a result of the growing awareness of genetics among the Indian population.
Companies are currently providing a variety of services that enable individuals to gain a more comprehensive understanding of their genetic composition, thereby facilitating the exploration and utilization of genomic data for preventive healthcare. Additionally, the market has experienced development as a result of the increasing accessibility and affordability of genomic studies, which are being facilitated by advancements in sequencing technologies.
An additional trend is the increasing investment in genomics research and the establishment of partnerships between academic institutions and biopharmaceutical companies in India. The promotion of innovation and technology transfer in this cooperative environment enhances the landscape for genomics research and applications.Moreover, the skill deficit is being addressed by initiatives to train professionals in genomics, ensuring that the workforce is prepared to meet the industry's changing requirements. Generally, the India genomics market has significant potential in the agricultural, environmental, and healthcare sectors, suggesting a multifaceted approach to leveraging genomics in the region.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
India is witnessing a significant increase in the prevalence of genetic disorders, which is driving the demand for genomic testing and research. According to the India Genetic Disease Foundation, over 10 million people in India suffer from rare genetic disorders, prompting healthcare initiatives to improve diagnostics and treatment options. Organizations such as the Indian Council of Medical Research are actively promoting genomics in healthcare to tackle this issue.Moreover, the government's focus on enhancing healthcare infrastructure and the introduction of the National Health Policy highlight the need for better genomic capabilities, leading to growth in the India Genomics Market. This strategic emphasis and urgent need for precise healthcare solutions are likely to catalyze advancements in genomic technologies, ultimately benefiting numerous patients who require early diagnosis and personalized treatment plans.
The rapid advancements in genomics technologies such as next-generation sequencing (NGS), bioinformatics, and personalized medicine are pivotal for the growth of the India Genomics Market Industry. Over the past few years, India has significantly invested in Research and Development (R&D), particularly in genomics. The Department of Biotechnology, under the Ministry of Science and Technology, has consistently funded initiatives aimed at enhancing genomic research capabilities.For example, the Indian government has sanctioned funding of over USD 150 million for genome sequencing projects in recent years. This influx of resources into genome-centric Research and Development is likely to accelerate the growth and innovation in genomic solutions within the country.
The Indian government has launched several initiatives to promote genomic research and innovation, serving as a crucial driver for the India Genomics Market Industry. The establishment of the Atal Innovation Mission and the Biotech Ignition Grant are examples of government-led efforts to encourage entrepreneurship in life sciences and genomics. With an estimated allocation of USD 400 million to promote biotechnology in the country, these initiatives foster collaboration between academic institutions and pharmaceutical companies, enhancing the scope of genomic applications.The increased support from governmental bodies opens new avenues for startups and established companies alike to invest in genomic technologies, further driving market growth.
The Application segment within the India Genomics Market plays a crucial role in shaping the future of healthcare and biotechnology in the country. With advancements in technology and a growing emphasis on precision medicine, this segment encompasses several key areas, including Drug Discovery, Clinical Diagnostics, Personalized Medicine, and Genetic Testing. Drug Discovery is gaining significant traction as pharmaceutical companies increasingly leverage genomic data to identify new therapeutic targets and enhance drug efficacy, thereby ensuring more successful treatment outcomes.
Clinical Diagnostics is also pivotal, as genetic testing facilitates early detection and accurate diagnosis of genetic disorders, ultimately improving patient management and care. Personalized Medicine stands out for its tailored treatment plans that cater to the individual's genetic makeup, leading to higher success rates and fewer side effects compared to traditional approaches. Meanwhile, Genetic Testing remains a dominating force, empowering individuals with knowledge about their health risks and enabling informed decision-making regarding treatments and lifestyle choices.
These elements collectively underscore the growing trend towards integrating genomics into mainstream healthcare, driven by the increasing demand for advanced medical solutions in India. Additionally, government initiatives aimed at promoting research and innovation in biotechnology are further fostering growth in this sector. Overall, the Application segment reflects a dynamic landscape where the combination of technology, healthcare, and genomics is set to provide innovative solutions and expand the boundaries of medical science in India.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The Technology segment of the India Genomics Market plays a pivotal role in advancing healthcare and research applications, reflecting the increasing importance of genomics in the country. The segment is diverse, encompassing technologies such as Sequencing, Microarray, PCR, and CRISPR. Sequencing technology, which allows for the detailed analysis of genetic material, is essential for personalized medicine and diagnostics, thus fostering significant advancements in treatment protocols.
Microarray technology serves as a powerful tool for understanding gene expression, crucial for research into genetic disorders and cancer profiling.PCR (Polymerase Chain Reaction) technology has revolutionized the field of molecular biology by enabling the amplification of DNA, which is foundational in various biological and medical research applications. CRISPR technology represents a breakthrough in gene editing, offering significant potential for therapeutic interventions and enhancements in agricultural biotechnology.
As the India Genomics Market evolves, investments in these technologies are expected to contribute to market growth and foster innovation while addressing challenges such as high costs and the need for skilled professionals.These advancements are also aligned with government initiatives in the health and biotechnology sectors, which aim to fortify India's position at the forefront of genomic research and application.
The India Genomics Market, particularly within the End Use segment, is experiencing robust growth driven by advancements in technology and increasing healthcare needs. Hospitals play a critical role, as they implement genomic services for personalized medicine and diagnostics, enhancing patient care significantly. Diagnostic Laboratories are also vital, leading in genetic testing procedures that aid in disease diagnosis and management, thus capturing a significant share of the market.
Research Institutes contribute to the India Genomics Market through extensive research and development initiatives, fostering innovation in genomics that benefits various health sectors.Pharmaceutical Companies leverage genomic data for drug discovery and development, making significant advancements in tailored therapies. The increasing collaboration among these entities enhances research outputs and improves treatment protocols. Overall, the End Use segment's contributions are essential in propelling the market forward, addressing the growing demand for genomic solutions in India.
The India Genomics Market has been witnessing significant growth fueled by advancements in technology, increasing awareness of preventive healthcare, and a growing emphasis on personalized medicine. The competitive landscape within this market is characterized by a mix of established players and emerging companies, all vying for greater market share. Companies are leveraging cutting-edge technologies such as next-generation sequencing and bioinformatics to develop innovative genomic solutions.
Regulatory policies and government initiatives aimed at promoting genomic research further intensify the competition, as businesses seek to establish themselves as leaders in this rapidly evolving domain. The entry of global players and collaborative partnerships between academia and industry continue to shape the competitive dynamics, making the India Genomics Market highly dynamic and competitive.Agilent Technologies has been a prominent player in the India Genomics Market, leveraging its expertise in life sciences and diagnostics to develop innovative genomic solutions.
The company boasts a comprehensive portfolio that includes platforms for next-generation sequencing, microarrays, and liquid chromatography. Agilent Technologies has established a significant presence in India, catering to research institutions, hospitals, and diagnostics laboratories. The company's strengths lie in its commitment to quality and reliability, supported by its advanced research and development capabilities.
Agilent's ability to provide customized solutions tailored to the needs of the Indian market further enhances its competitive edge. With continuous investments in technology and localization of its products, Agilent Technologies is well-positioned to capture growth opportunities in the burgeoning genomics sector in India.Covance, with its strong foothold in the India Genomics Market, offers a wide range of services, including genomic testing, biomarker development, and data analytics. The company is well-regarded for its focus on providing integrated laboratory services that cater to the specific needs of the pharmaceutical and biotechnology sectors.
Covance's strengths lie in its extensive experience and robust methodologies, which enable clients to significantly streamline their research processes. The company has engaged in strategic mergers and acquisitions, enhancing its capabilities and market reach in the region. Covance's commitment to innovation and quality is attracting a growing number of partnerships, particularly in the field of personalized medicine research and clinical trials. Furthermore, Covance aims to continue expanding its presence in India through collaborations that foster advancements in genomic technologies, underscoring its position as a key player in this competitive landscape.
The India Genomics Market has seen significant developments lately, particularly with companies such as Illumina and Thermo Fisher Scientific enhancing their presence through advanced genomic technologies. In September 2023, Agilent Technologies launched a new product aimed at improving genomic sequencing, indicating a shift towards more accurate diagnostics.
Notably, in August 2023, Mapmygenome secured funding to expand its personalized genomics services, showcasing the growing interest in consumer-oriented genetic testing. Current market dynamics suggest that Mylab Discovery Solutions and Niramai are making strides in integrated genomic research and disease detection, contributing to the sector's growth.In terms of mergers and acquisitions, Avesthagen's acquisition of a smaller biotech firm in July 2023 highlights the consolidation trend in the market. Roche Diagnostics is also actively pursuing collaborations to enhance its genomic capabilities.
The overall valuation of the India Genomics Market has experienced a robust increase, driven by innovation and investment. Over the past few years, significant events, such as the partnership between Strand Life Sciences and BGI Genomics in early 2022, illustrate the collaborative spirit that characterizes this rapidly evolving sector.
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.51(USD Billion) |
| MARKET SIZE 2024 | 1.63(USD Billion) |
| MARKET SIZE 2035 | 3.25(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.503% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Agilent Technologies, Covance, Mapmygenome, Thermo Fisher Scientific, Mylab Discovery Solutions, Avesthagen, Roche Diagnostics, Genetics and IVF Institute, Niramai, Illumina, Strand Life Sciences, QInstruments, GeneSeek, Zymergen, BGI Genomics |
| SEGMENTS COVERED | Application, Technology, End Use |
| KEY MARKET OPPORTUNITIES | Personalized medicine development, Gene editing advancements, Agricultural genomics applications, Biobanking and data analytics, Genetic testing for rare diseases |
| KEY MARKET DYNAMICS | Technological advancements, Increasing healthcare awareness, Government support initiatives, Rising research funding, Growing demand for personalized medicine |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Genomics Market is projected to be valued at 1.63 USD Billion in 2024.
The market is expected to reach 3.25 USD Billion by the year 2035.
The expected CAGR for the India Genomics Market is 6.503 percent from 2025 to 2035.
By 2035, the Drug Discovery application segment is expected to have the highest value at 1.1 USD Billion.
The Clinical Diagnostics segment is anticipated to be valued at 0.45 USD Billion in 2024.
Key players in the market include Agilent Technologies, Thermo Fisher Scientific, and Illumina.
Personalized Medicine is expected to grow to 0.6 USD Billion by 2035.
The Genetic Testing application is valued at approximately 0.33 USD Billion in 2024.
There are significant opportunities in personalized medicine and drug discovery applications within the market.
The market faces challenges such as regulatory hurdles and the need for advanced infrastructure as it grows.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
